Dactolisib
CAS No. 915019-65-7
Dactolisib ( NVP-BEZ235;BEZ-235 )
Catalog No. M16571 CAS No. 915019-65-7
A potent, dual ATP-competitive pan-class I PI3K and mTOR inhibitor for p110α/γ/δ/β and mTOR(p70S6K) with IC50 of 4 nM /5 nM /7 nM /75 nM /6 nM, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
25MG | 35 | In Stock |
|
50MG | 47 | In Stock |
|
100MG | 58 | In Stock |
|
200MG | 97 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDactolisib
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, dual ATP-competitive pan-class I PI3K and mTOR inhibitor for p110α/γ/δ/β and mTOR(p70S6K) with IC50 of 4 nM /5 nM /7 nM /75 nM /6 nM, respectively.
-
DescriptionA potent, dual ATP-competitive pan-class I PI3K and mTOR inhibitor for p110α/γ/δ/β and mTOR(p70S6K) with IC50 of 4 nM /5 nM /7 nM /75 nM /6 nM, respectively; effectively and specifically blocks the dysfunctional activation of the PI3K pathway, inducing G(1) arrest; demonstrates antitumor activity in in vivo models of human cancer.Kidney Cancer Phase 2 Discontinued
-
SynonymsNVP-BEZ235;BEZ-235
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorATR;mTOR(p70S6K);p110α;p110γ;p110δ;p110β
-
Research AreaCancer
-
IndicationKidney Cancer
Chemical Information
-
CAS Number915019-65-7
-
Formula Weight469.54
-
Molecular FormulaC30H23N5O
-
Purity>98% (HPLC)
-
SolubilityDMSO: 8.75 mg/mL
-
SMILESCC(C1=CC=C(N(C2=C3C=NC4=CC=C(C5=CC6=CC=CC=C6N=C5)C=C24)C(N3C)=O)C=C1)(C)C#N
-
Chemical NameBenzeneacetonitrile, 4-[2,3-dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo[4,5-c]quinolin-1-yl]-.alpha.,.alpha.-dimethyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Maira SM, et al. Mol Cancer Ther. 2008 Jul;7(7):1851-63.
2. Serra V, et al. Cancer Res. 2008 Oct 1;68(19):8022-30.
3. Schnell CR, et al. Cancer Res. 2008 Aug 15;68(16):6598-607.
2. Serra V, et al. Cancer Res. 2008 Oct 1;68(19):8022-30.
3. Schnell CR, et al. Cancer Res. 2008 Aug 15;68(16):6598-607.
molnova catalog
related products
-
LTURM34
LTURM34 is an inhibitor of DNA-PK with IC50 of 34 nM. LTURM34 displays effective antiproliferative activity in a wide range of tumor cell lines.
-
IPI-3063
IPI-3063 is an effective and selective inhibitor of PI3K p110δ (IC50: 2.5?±?1.2 nM).
-
PQR-530
PQR-530 (PQR530) is a potent, BBB penetrant, dual pan-PI3K/mTOR inhibitor.